首页> 外国专利> METHOD FOR PREPARING RHESUS MACAQUE DIABETES MELLITUS TYPE 2 MODEL

METHOD FOR PREPARING RHESUS MACAQUE DIABETES MELLITUS TYPE 2 MODEL

机译：猕猴糖尿病2型模型的制备方法

展开▼

页面导航

摘要

著录项

相似文献

摘要

A method for preparing a Rhesus macaque diabetes mellitus type 2 model, comprising the following steps: (1) a Rhesus macaque is fed a high-fat and high-cholesterol feed twice per day at a feeding amount of 0.3-0.4 kg/instance/animal, where the feed comprises raw materials of the following proportions by weight: 78 parts of a standard monkey feed, 15 parts of an animal fat, 5 parts of a sugar, and 2 parts of cholesterol; and, (2) after 24 months, streptozotocin of a dosage of 25 mg/kg is administered to the Rhesus macaque once per week for 2 successive instances. By employing a scheme of long-term feeding of the high-fat and high-cholesterol feed and intravenous injection of a small dose of streptozotocin for joint modeling, a Rhesus macaque diabetes mellitus type 2 model is successfully induced. 展开▼

机译：一种制备2型糖尿病猕猴模型的方法，该方法包括以下步骤：（1）给2型猕猴高脂高胆固醇饲料喂养2次。每天的添加量为0.3-0.4千克/实例/动物，其中饲料包含以下重量比例的原料：78份标准猴子饲料，15份动物脂肪，5份糖，和2份胆固醇; （2）24个月后，每周连续两次对 Rhesus猕猴施用25 mg / kg剂量的链脲佐菌素。通过长期饲喂高脂和高胆固醇饲料并静脉注射小剂量链脲佐菌素的方案进行联合建模，成功诱导了2型糖尿病的猕猴。 展开▼

著录项

公开/公告号WO2014202022A1

专利类型

公开/公告日2014-12-24

原文格式PDF

申请/专利权人 WEST CHINA HOSPITAL SICHUAN UNIVERSITY;SICHUAN HEALTH CITY BIOTECH CO. INC.;
展开▼

申请/专利号WO2014CN80412

发明设计人 CHEN YOUNAN;WANG LI;REN YAN;TIAN HAOMING;ZHONG ZHIHUI;CHENG JINGQIU;LU YANRONG;LIU JINGPING;LI XINLI;YANG GUANG;ZHANG JIE;LIAO GUANGNENG;LI HONGXIA;
展开▼

申请日2014-06-20

分类号A01K67/02;A23K1/18;A61K31/7008;

国家 WO

入库时间 2022-08-21 15:09:28

相似文献

专利

外文文献

中文文献

1. 用于延迟新发作2型糖尿病的发生和用于减慢2型糖尿病的进展和治疗2型糖尿病的方法 [P] . 中国专利： CN112888432A . 2021-06-01

2. 一种小型猪2型糖尿病模型的制备方法 [P] . 中国专利： CN103858820A . 2014-06-18

3. METHOD FOR PREPARING RHESUS MACAQUE METABOLIC SYNDROME MODEL [P] . 世界知识产权组织专利： WO2014202023A1 . 2014-12-24

机译： 猕猴代谢综合症模型的制备方法

4. Use of melagatran or a pharmaceutically acceptable derivative thereof, methods of treating type i diabetes mellitus, langerhans islet graft cell transplantation, to improve insulin independence in type i diabetes mellitus patients, and reaction treatment instant blood mediated inflammatory drug, pharmaceutical formulation for use in the treatment of type i diabetes mellitus, parts kit, and method of manufacturing a parts kit. [P] . BR0306798A . 2004-12-07

机译：美拉加群或其药学上可接受的衍生物的用途，治疗i型糖尿病的方法，兰格汉斯胰岛移植细胞移植，改善i型糖尿病患者的胰岛素独立性以及反应治疗速溶血液介导的炎性药物，用于该药物的药物制剂I型糖尿病的治疗，零件套件以及零件套件的制造方法。

5. compound, pharmaceutical composition, and methods of treating type 2 diabetes mellitus, delaying the onset of type 2 diabetes mellitus, treating hyperglycemia, diabetes or insulin resistance, obesity, syndrome x, a lipid disorder, atherosclerosis, and a condition [P] . BRPI0511703B1 . 2018-07-17

机译：化合物，药物组合物和治疗2型糖尿病的方法，延迟2型糖尿病的发作，治疗高血糖症，糖尿病或胰岛素抵抗，肥胖症，综合症x，脂质疾病，动脉粥样硬化和疾病

1. Nerve growth factor and inducible nitric oxide synthase expression in the mesencephalon and diencephalon, as well as visual- and auditory-related nervous tissues, in a macaque model of type 2 diabetes [J] . Qihui Luo, Wentao Liu, Jingyao Chen, 中国神经再生研究（英文版） . 2012,第004期

2. Comparative evaluation in treating qi-yin deficiency and phlegm stasis syndrome of type 2 diabetes mellitus in a rat model [J] . Zongchun Yang, Jing Zhao, Jinna Liu, 中医科学杂志（英文） . 2019,第001期

3. SPONTANEOUS AMYLOIDOSIS AND DIABETES MELLITUS IN A RHESUS MACAQUE (MACACA MULATTA) [J] . HAND AN HILAL ARSLAN, CEVAT NISBET, TOLGA GUVENC Bulletin of the Veterinary Institute in Pulawy . 2007,第4期

4. Type 2 Diabetes Mellitus Non-genetic Rhesus Monkey Model Induced by High Fat and High Sucrose Diet [J] . Lu Shuai-yao, Qi Su-dong, Zhao Yuan, Experimental and clinical endocrinology and diabetes: Official journal, German Society of Endocrinology [and] German Diabetes Association . 2015,第1期

5. Type 2 Diabetes Mellitus Non-genetic Rhesus Monkey Model Induced by High Fat and High Sucrose Diet [J] . Lu Shuai-yao, Qi Su-dong, Zhao Yuan, Experimental and clinical endocrinology and diabetes: Official journal, German Society of Endocrinology [and] German Diabetes Association . 2015,第1期

6. Towards a mobile solution for predicting illness in Type 1 Diabetes Mellitus: Development of a prediction model for detecting risk of illness in Type 1 Diabetes prior to symptom onset [C] . Lauritzen Jonas N, Arsand Eirik, Van Vuurden Klaske, 2011 2nd International Conference on Wireless Communication, Vehicular Technology, Information Theory and Aerospace Electronic Systems Technology . 2011

7. Infections and systemic disease: Methodological issues for periodontal infection models and an application to type 2 diabetes mellitus risk factor epidemiology. [D] . Demmer, Ryan Thomas. 2005

8. Rationale and methods for the Exercise for Type 1 Diabetes Education program: a pilot randomized controlled trial of an education program to support adults with type 1 diabetes mellitus (T1DM) to undertake exercise [O] . Parth Narendran, Niamh Quann, Dinesh Nagi, 2019

9. Poster session 2Morphogenetic mechanisms290MiR-133 regulates retinoic acid pathway during early cardiac chamber specification291Bmp2 regulates atrial differentiation through miR-130 during early heart looping formationDevelopmental genetics294Association of deletion allele of insertion/deletion polymorphism in alpha 2B adrenoceptor gene and hypertension with or without type 2 diabetes mellitus295Association of G1359A polymorphism of the endocannabinoid type 1 receptor (CNR1) with coronary artery disease (CAD) with type 2 diabetes mellitusCell growth, differentiation and stem cells - Vascular298Gamma-secretase inhibitor prevents proliferation and migration of ductus arteriosus smooth muscle cells: a role of Notch signaling in postnatal closure of ductus arteriosus299Mesenchymal stromal-like cells (MLCs) derived from induced pluripotent stem (iPS) cells: a promising therapeutic option to promote neovascularization300Sonic Hedgehog promotes mesenchymal stem cell differentiation to vascular smooth muscle cells in cardiovacsular disease301Proinflammatory cytokine secretion and epigenetic modification in endothelial cells treated LPS-GinfivalisCell death and apoptosis - Vascular304Mitophagy acts as a safeguard mechanism against human vascular smooth muscle cell apoptosis induced by atherogenic lipidsTranscriptional control and RNA species - Vascular307MicroRNA-34a role in vascular calcification308Local delivery of a miR-146a inhibitor utilizing a clinically applicable approach attenuates neointima formation after vascular injury309Long noncoding RNA landscape of hypoxic endothelial cells310Specific circulating microRNAs levels associate with hypertension, hyperglycemia and dysfunctional HDL in acute coronary syndrome patientsCytokines and cellular inflammation - Vascular313Phosphodiesterase5A up-regulation in vascular endothelium under pro-inflammatory conditions: a newly disclosed anti-inflammatory activity for the omega-3polyunsaturated aatty acid docosahexaenoic acid314Cardiovascular risk modifying with extra-low dose anticytokine drugs in rhematoid arthritis315Conversion of human M-CSF macrophages into foam cells reduces their proinflammatory responses to classical M1-polarizing activation316Lymphocytic myocarditis coincides with increased plaque inflammation and plaque hemorrhage in coronary arteries, facilitating myocardial infarction317Serum osteoprotegerin level predictsdeclined numerous of circulating endothelial- derived and mononuclear-derived progenitor cells in patients with metabolic syndromeGrowth factors and neurohormones - Vascular320Effect of gastrin-releasing peptide (GRP) on vascular inflammationSignal transduction - Heart323A new synthetic peptide regulates hypertrophy in vitro through means of the inhibition of nfkb324Inducible fibroblast-specific knockout of p38 alpha map kinase is cardioprotective in a mouse model of isoproterenol-induced cardiac hypertrophy325Regulation of beta-adrenoceptor-evoked inotropic responses by inhibitory G protein, adenylyl cyclase isoforms 5 and 6 and phosphodiesterases326Binding to RGS3 and stimulation of M2 muscarinic acetylcholine receptors modulates the substrate specificity of p190RhoGAP in cardiac myocytes327Cardiac regulation of post-translational modifications, parylation and deacetylation in LMNA dilated cardiomyopathy mouse model328Beta-adrenergic regulation of the b56delta/pp2a holoenzyme in cardiac myocytes through b56delta phosphorylation at serine 573Nitric oxide and reactive oxygen species - Vascular331Oxidative stress-induced miR-200c disrupts the regulatory loop among SIRT1, FOXO1 and eNOS332Antioxidant therapy prevents oxidative stress-induced endothelial dysfunction and Enhances Wound Healing333Morphological and biochemical characterization of red blood cell in coronary artery diseaseCytoskeleton and mechanotransduction - Heart336Novel myosin activator, JSH compounds, increased myocardial contractility without chronotropic effect in ratsExtracellular matrix and fibrosis - Vascular339Ablation of Toll-like receptor 9 causes cardiac rupture after myocardial infarction by attenuating proliferation and differentiation of cardiac fibroblasts340Altered vascular remodeling in the mouse hind limb ischemia model in Factor VII activating protease (FSAP) deficiencyVasculogenesis, angiogenesis and arteriogenesis343Pro-angiogenic effects of proly-hydroxylase inhibitors and their potential for use in a novel strategy of therapeutic angiogenesis for coronary total occlusion344Nrf2 drives angiogenesis in transcription-independent manner: new function of the master regulator of oxidative stress response345Angiogenic gene therapy, despite efficient vascular growth, is not able to improve muscle function in normoxic or chronically ischemic rabbit hindlimbs -role of capillary arterialization and shunting346Effect of PAR-1 inhibition on collateral vessel growth in the murine hind limb model347Quaking is a key regulator of endothelial cell differentiation, neovascularization and angiogenesis348"Emerging angiogenesis" in the chick chorioallantoic membrane (CAM). An in vivo study349Exosomes from cardiomyocyte progenitor cells and mesenchymal stem cells stimulate angiogenesis in vitro and in vivo via EMMPRINEndothelium352Reciprocal regulation of GRK2 and bradykinin receptor stimulation modulate Ca2+ intracellular level in endothelial cells353The roles of bone morphogenetic proteins 9 and 10 in endothelial inflammation and atherosclerosis354The contribution of GPR55 to the L-alpha-lysophosphatidylinositol-induced vasorelaxation in isolated human pulmonary arteries355The endothelial protective ACE inhibitor Zofenoprilat exerts anti-inflammatory activities through H2S production356A new class of glycomimetic drugs to prevent free fatty acid-induced endothelial dysfunction357Endothelial progenitor cells to apoptotic endothelial cell-derived microparticles ration differentiatesas preserved from reduced ejection fractionheart failure358Proosteogenic genes are activated in endothelial cells of patients with thoracic aortic aneurysm359Endothelin ETB receptors mediate relaxing responses to insulin in pericardial resistance arteries from patients with cardiovascular disease (CVD)Smooth muscle and pericytes362CX3CR1 positive myeloid cells regulate vascular smooth muscle tone by inducing calcium oscillations via activation of IP3 receptors363A novel function of PI3Kg on cAMP regulation, role in arterial wall hyperplasia through modulation of smooth muscle cells proliferation364NRP1 and NRP2 play important roles in the development of neointimal hyperplasia in vivo365Azithromycin induces autophagy in aortic smooth muscle cellsCoagulation, thrombosis and platelets368The real time in vivo evaluation of platelet-dependent aldosterone prothrombotic action in mice369Development of a method for in vivo detection of active thrombi in mice370The antiplatelet effects of structural analogs of the taurine chloramine371The influence of heparin anticoagulant drugs on functional state of human platelets372Regulation of platelet aggregation and adenosine diphosphate release by d dimer in acute coronary syndrome (in vitro study)Oxygen sensing, ischaemia and reperfusion375Sirtuin 5 mediates brain injury in a mouse model of cerebral ischemia-reperfusion376Abscisic acid: a new player in cardiomyocyte protection from ischaemia?377Protective effects of ultramicronized palmitoylethanolamide (PEA-um) in myocardial ischaemia and reperfusion injury in vivo378Identification of stem cell-derived cardiomyocytes using cardiac specific markers and additional testing of these cells in simulated ischemia/reperfusion system379Single-dose intravenous metformin treatment could afford significant protection of the injured rat kidney in an experimental model of ischemia-reperfusion380Cardiotoxicity of long acting muscarinic receptor antagonists used for chronic obstructive pulmonary disease381Dependence antioxidant potential on the concentration of amino acids382The impact of ischemia-reperfusion on physiological parameters,apoptosis and ultrastructure of rabbit myocardium with experimental aterosclerosisMitochondria and energetics385MicroRNA-1 dependent regulation of mitochondrial calcium uniporter (MCU) in normal and hypertrophied hearts386Mitochondrial homeostasis and cardioprotection: common targets for desmin and aB-crystallin387Overexpression of mitofusin-2 (Mfn2) and associated mitochondrial dysfunction in the diabetic heart388NO-dependent prevention of permeability transition pore (MPTP) opening by H2S and its regulation of Ca2+ accumulation in rat heart mitochondria389G protein coupled receptor kinase 2 (GRK2) is fundamental in recovering mitochondrial morphology and function after exposure to ionizing radiation (IR)Gender issues392Sex differences in pulmonary vascular control; focus on the nitric oxide pathwayAging395Heart failure with preserved ejection fraction develops when feeding western diet to senescence-accelerated mice396Cardiovascular markers as predictors of cognitive decline in elderly hypertensive patients397Changes in connexin43 in old rats with volume overload chronic heart failureGenetics and epigenetics400Calcium content in the aortic valve is associated with 1G>2G matrix metalloproteinase 1 polymorphism401Neuropeptide receptor gene s (NPSR1) polymorphism and sleep disturbances402Endothelin-1 gene Lys198Asn polymorphism in men with essential hypertension complicated and uncomplicated with chronic heart failure403Association of common polymorphisms of the lipoprotein lipase and pon1 genes with the metabolic syndrome in a sample of community participantsGenomics, proteomics, metabolomics, lipidomics and glycomics405Gene expression quantification using multiplexed color-coded probe pairs to determine RNA content in sporadic cardiac myxoma406Large-scale phosphorylation study of the type 2 diabetic heart subjected to ischemia / reperfusion injury407Transcriptome-based identification of new anti-inflammatory properties of the olive oil hydroxytyrosol in vascular endothelial cell under basal and proinflammatory conditions408Gene polymorphisms combinations and risk of myocardial infarctionComputer modelling, bioinformatics and big data411Comparison of the repolarization reserve in three state-of-the-art models of the human ventricular action potentialMetabolism, diabetes mellitus and obesity414Endothelial monocyte-activating polypeptide-II improves heart function in type -I Diabetes mellitus415Admission glucose level is independent predictor of impaired left ventricular function in patients with acute myocardial infarction: a two dimensional speckle-tracking echocardiography study416Association between biochemical markers of lipid profile and inflammatory reaction and stiffness of the vascular wall in hypertensive patients with abdominal obesity417Multiple common co-morbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress and myocardial stiffening418Investigating the cardiovascular effects of antiretroviral drugs in a lean and high fat/sucrose diet rat model of obesity419Statins in the treatment of non-alcoholic steatohepatitis (NASH). Our experience from a 2-year prospective study in Constanta County, Romania420Epicardial adipose tissue as a predictor of cardiovascular outcome in patients with ACS undergoing PCI?Arterial and pulmonary hypertension423Dependence between heart rhythm disorers and ID polymorphism of ACE gene in hypertensive patients424Molecular mechanisms underlying the beneficial effects of Urocortin 2 in pulmonary arterial hypertension425Inhibition of TGf-b axis and action of renin-angiotensin system in human ascending aorta aneurysms426Early signs of microcirculation and macrocirculation abnormalities in prehypertension427Vascular smooth muscle cell-expressed Tie-2 controls vascular tone428Cardiac and vascular remodelling in the development of chronic thrombo-embolic pulmonary hypertension in a novel swine modelBiomarkers431Arrhythmogenic cardiomyopathy: a new, non invasive biomarker432Can circulating microRNAs distinguish type 1 and type 2 myocardial infarction?433Design of a high-throughput multiplex proteomics assay to identify left ventricular diastolic dysfunction in diabetes434Monocyte-derived and P-selectin-carrying microparticles are differently modified by a low fat diet in patients with cardiovascular risk factors who will and who will not develop a cardiovascular event435Red blood cell distribution width assessment by polychromatic interference microscopy of thin films in chronic heart failure436Invasive and noninvasive evaluation of quality of radiofrequency-induced cardiac denervation in patients with atrial fibrillation437The effect of therapeutic hypothermia on the level of brain derived neurotrophic factor (BDNF) in sera following cardiopulmonary resustitation438Novel biomarkers to predict outcome in patients with heart failure and severe aortic stenosis439Biological factors linking depression and anxiety to cardiovascular disease440Troponins and myoglobin dynamic at coronary arteries graftingInvasive, non-invasive and molecular imaging443Diet composition effects on the genetic typing of the mouse ob mutation: a micro-ultrasound characterization of cardiac function, macro and micro circulation and liver steatosis444Characterization of pig coronary and rabbit aortic lesions using IV-OCT quantitative analysis: correlations with histologyGene therapy and cell therapy447Enhancing the survival and angiogenic potential of mouse atrial mesenchymal cells448VCAM-1 expression in experimental myocardial infarction and its relation to bone marrow-derived mononuclear cell retentionTissue engineering451Advanced multi layered scaffold that increases the maturity of stem cell-derived human cardiomyocytes452Response of engineered heart tissue to simulated ischemia/reperfusion in the presence of acute hyperglycemic conditions453Serum albumin hydrogels prevent de-differentiation of neonatal cardiomyocytes454A novel paintbrush technique for transfer of low viscosity ultraviolet light curable cyan methacrylate on saline immersed in-vitro sheep heart [O] . V Garcia-Martinez, C Lopez Sanchez, W Hamed, 2016

1. Autologous bone marrow derived stem cell therapy in patients with type 2 diabetes mellitus-defining adequate administration methods [J] . Vikas Sood ,Anil Bhansali ,Bhagwant Rai Mittal . 世界糖尿病杂志：英文版（电子版） . 2017,第7期

2. Comparison between different methods of urine collection for estimation of albumin-creatinine ratio in patients with type-2 diabetes mellitus [J] . Subinay Datta ,Mrinal Pal . 生物化学进展（英文） . 2013,第4期

3. Impaired contractility and remodeling of the upper gastrointestinal tract in diabetes mellitus type-1 [J] . Jens BrΦndum FrΦkjΦr ,SΦren Due Andersen ,Niels EjskjΦr . 世界胃肠病学杂志：英文版 . 2007,第36期

4. 2型糖尿病并糖尿病大血管病变模型的建立 [C] . 彭聪 ,郑承红 . 第三次全国中西医结合内分泌代谢病学术大会暨糖尿病论坛 . 2010

5. 2型糖尿病模型的建立与评价及黄精多糖对2型糖尿病大鼠的影响 [A] . 王利 . 2008